Diabetes, Vol 49, Issue 7 1078-1083, Copyright © 2000 by American Diabetes Association

ARTICLES

Fatty acid oxidation and the regulation of malonyl-CoA in human muscle

PN Bavenholm, J Pigon, AK Saha, NB Ruderman and S Efendic
Department of Emergency and Cardiovascular Medicine, Karolinska Hospital and Institute, Stockholm, Sweden.

Questions concerning whether malonyl-CoA is regulated in human muscle and whether malonyl-CoA modulates fatty acid oxidation are still unanswered. To address these questions, whole-body fatty acid oxidation and the concentration of malonyl-CoA, citrate, and malate were determined in the vastus lateralis muscle of 16 healthy nonobese Swedish men during a sequential euglycemic-hyperinsulinemic clamp. Insulin was infused at rates of 0.25 and 1.0 mU x kg(-1) x min(-1), and glucose was infused at rates of 2.0 +/- 0.2 and 8.1 +/- 0.7 mg x kg(-1) x min(-1), respectively. During the low-dose insulin infusion, whole-body fatty acid oxidation, as determined by indirect calorimetry, decreased by 22% from a basal rate of 0.94 +/- 0.06 to 0.74 +/- 0.07 mg x kg(-1) x min(-1) (P = 0.005), but no increase in malonyl-CoA was observed. In contrast, during the high-dose insulin infusion, malonyl-CoA increased from 0.20 +/- 0.01 to 0.24 +/- 0.01 nmol/g (P < 0.001), and whole-body fatty acid oxidation decreased by an additional 41% to 0.44 +/- 0.06 mg x kg(-1) x min(-1) (P < 0.001). The increase in malonyl-CoA was associated with 30-50% increases in the concentrations of citrate (102 +/- 6 vs. 137 +/- 7 nmol/g, P < 0.001), an allosteric activator of the rate-limiting enzyme in the malonyl-CoA formation, acetyl-CoA carboxylase, and malate (80 +/- 6 vs. 126 +/- 9 nmol/g, P = 0.002), an antiporter for citrate efflux from the mitochondria. Significant correlations were observed between the concentration of malonyl-CoA and both glucose utilization (r = 0.53, P = 0.002) and the sum of the concentrations of citrate and malate (r = 0.52, P < 0.001), a proposed index of the cytosolic concentration of citrate. In addition, an inverse correlation between malonyl-CoA concentration and fatty acid oxidation was observed (r = -0.32, P = 0.03). The results indicate that an infusion of insulin and glucose at a high rate leads to increases in the concentration of malonyl-CoA in skeletal muscle and to decreases in whole-body and, presumably, muscle fatty acid oxidation. Furthermore, they suggest that the increase in malonyl-CoA in this situation is due, at least in part, to an increase in the cytosolic concentration of citrate. Because cytosolic citrate is also an inhibitor of phosphofructokinase, an attractive hypothesis is that changes in its concentration are part of an autoregulatory mechanism by which glucose modulates its own use and the use of fatty acids as fuels for skeletal muscle.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. B. Stephens, D. Constantin-Teodosiu, and P. L. Greenhaff New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle J. Physiol., June 1, 2007; 581(2): 431 - 444. [Abstract] [Full Text] [PDF]

				J. E. Kuhl, N. B. Ruderman, N. Musi, L. J. Goodyear, M. E. Patti, S. Crunkhorn, D. Dronamraju, A. Thorell, J. Nygren, O. Ljungkvist, et al. Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1296 - E1303. [Abstract] [Full Text] [PDF]

				B. Kiens Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance Physiol Rev, January 1, 2006; 86(1): 205 - 243. [Abstract] [Full Text] [PDF]

				D. S. Rubink and W. W. Winder Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase J Appl Physiol, April 1, 2005; 98(4): 1221 - 1227. [Abstract] [Full Text] [PDF]

				N. Yang, J. S. Kays, T. R. Skillman, L. Burris, T. W. Seng, and C. Hammond C75 [4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic Acid] Activates Carnitine Palmitoyltransferase-1 in Isolated Mitochondria and Intact Cells without Displacement of Bound Malonyl CoA J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 127 - 133. [Abstract] [Full Text] [PDF]

				C. Roepstorff, N. Halberg, T. Hillig, A. K. Saha, N. B. Ruderman, J. F. P. Wojtaszewski, E. A. Richter, and B. Kiens Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E133 - E142. [Abstract] [Full Text] [PDF]

				T. W. Zderic, C. J. Davidson, S. Schenk, L. O. Byerley, and E. F. Coyle High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E217 - E225. [Abstract] [Full Text] [PDF]

				G. Perseghin, G. Lattuada, M. Danna, L. P. Sereni, P. Maffi, F. De Cobelli, A. Battezzati, A. Secchi, A. Del Maschio, and L. Luzi Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1174 - E1181. [Abstract] [Full Text] [PDF]

				J. F. P. Wojtaszewski, C. MacDonald, J. N. Nielsen, Y. Hellsten, D. G. Hardie, B. E. Kemp, B. Kiens, and E. A. Richter Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E813 - E822. [Abstract] [Full Text] [PDF]

				P. N. Bavenholm, J. Kuhl, J. Pigon, A. K. Saha, N. B. Ruderman, and S. Efendic Insulin Resistance in Type 2 Diabetes: Association with Truncal Obesity, Impaired Fitness, and Atypical Malonyl Coenzyme A Regulation J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 82 - 87. [Abstract] [Full Text] [PDF]

				A. J. Yee and L. P. Turcotte Insulin fails to alter plasma LCFA metabolism in muscle perfused at similar glucose uptake Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E73 - E77. [Abstract] [Full Text] [PDF]

				G. R. Steinberg, M. L. Parolin, G. J. F. Heigenhauser, and D. J. Dyck Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E187 - E192. [Abstract] [Full Text] [PDF]

				J. N. Nielsen, J. Vissing, J. F. P. Wojtaszewski, R. G. Haller, N. Begum, and E. A. Richter Decreased insulin action in skeletal muscle from patients with McArdle's disease Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1267 - E1275. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				W. W. Winder Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle J Appl Physiol, September 1, 2001; 91(3): 1017 - 1028. [Abstract] [Full Text] [PDF]

				T.-S. TSAO, J. LI, K. S. CHANG, A. E. STENBIT, D. GALUSKA, J. E. ANDERSON, J. R. ZIERATH, R. J. MCCARTER, and M. J. CHARRON Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity FASEB J, April 1, 2001; 15(6): 958 - 969. [Abstract] [Full Text] [PDF]

				R. Fabris, E. Nisoli, A. M. Lombardi, C. Tonello, R. Serra, M. Granzotto, I. Cusin, F. Rohner-Jeanrenaud, G. Federspil, M. O. Carruba, et al. Preferential Channeling of Energy Fuels Toward Fat Rather Than Muscle During High Free Fatty Acid Availability in Rats Diabetes, March 1, 2001; 50(3): 601 - 608. [Abstract] [Full Text]

				T. Hajri, A. Ibrahimi, C. T. Coburn, F. F. Knapp Jr., T. Kurtz, M. Pravenec, and N. A. Abumrad Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial Hypertrophy J. Biol. Chem., June 22, 2001; 276(26): 23661 - 23666. [Abstract] [Full Text] [PDF]